HCA Healthcare remains undervalued despite strong YTD outperformance, supported by robust profit and cash flow growth. HCA is positioned to benefit from an aging U.S. population, expanding hospital capacity, and leading market share in acute care services. Current valuation implies zero profit growth, yet HCA has consistently grown NOPAT 7%+ annually since 2007 and offers 40%+ upside with consensus growth.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
| Health Care Providers & Services Industry | Healthcare Sector | Samuel N. Hazen CEO | LSE Exchange | US40412C1018 ISIN |
| US Country | 226,000 Employees | 15 Dec 2025 Last Dividend | - Last Split | 10 Mar 2011 IPO Date |
HCA Healthcare, Inc., with its extensive network of subsidiaries, stands as a prominent owner and operator of hospitals and healthcare-related facilities across the United States. Established in 1968 and headquartered in Nashville, Tennessee, HCA Healthcare began as HCA Holdings, Inc. It has grown to operate a wide range of healthcare facilities, including general and acute care hospitals that provide comprehensive medical and surgical services. These services cater to both inpatient and outpatient needs, with a strong emphasis on quality care across various specialties such as intensive care, cardiac care, diagnostics, and emergency services. The organization focuses on delivering high-quality patient care and enhancing the health of the communities it serves.
HCA Healthcare, Inc. offers a broad spectrum of healthcare services through its extensive network of facilities, including: